PubMed-compiled information sheet
This sheet was compiled from PubMed (NIH) abstracts using AI assistance. Every factual claim is cited to a real PubMed article (see the source list). It has not yet been human-reviewed — confirm with a healthcare provider before use.
Compiled from 30 PubMed articles · model: gemma4:31b
Summary
Background
Active compounds
Mechanism of action
Clinical evidence
Purified flower extract containing spirilloxanthin significantly improved learning and memory and reduced free radical production [PMID:40437285]
Extract concentrations of 250-1000 μg/ml were cytotoxic against MCF-7 (breast) and HepG2 (liver) cell lines, but not against A-549 (lung) cells [PMID:27161012]
Pseudotaraxasterol-3β-acetate showed moderate to weak activity against L. infantum, T. brucei, and P. falciparum; 16β-hydroxy-pseudotaraxasterol-3β-palmitate showed moderate activity against L. infantum [PMID:27154232]
Safety & adverse effects
Evidence summary
PubMed sources
- 1.PMID: 35441891 (2023) — Investigating the phytotoxic potential of Verbesina encelioides: effect on growth and performance of co-occurring weed species. · Protoplasma
- 2.PMID: 27161012 (2016) — Verbesina encelioides: cytotoxicity, cell cycle arrest, and oxidative DNA damage in human liver cancer (HepG2) cell line. · BMC complementary and alternative medicine
- 3.PMID: 41488798 (2026) — Characterization of Verbesina encelioides (Asteroideae, Asteraceae) Chloroplast Genome and Phylogenetic Insights. · Ecology and evolution
- 4.PMID: 27154232 (2017) — Antiprotozoal activity of major constituents from the bioactive fraction of Verbesina encelioides. · Natural product research
- 5.PMID: 40437285 (2025)